Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 216-644-2 | CAS number: 1633-22-3
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Dichlorotricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaene, mixed isomers
- EC Number:
- 249-236-8
- EC Name:
- Dichlorotricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaene, mixed isomers
- Cas Number:
- 28804-46-8
- Molecular formula:
- C16H14Cl2
- IUPAC Name:
- Unknown constituents
- Test material form:
- solid: granular
1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA:J
- Remarks:
- CrHsd
- Sex:
- female
Study design: in vivo (LLNA)
- Vehicle:
- methyl ethyl ketone
- Concentration:
- In the preliminary assay, dose concentrations of 1%, 2.5%, 5.0% and 10% (w/v) in methyl ethyl ketone (MEK) revealed no erythema and ear thickness increases was less than 25%. Therefore, dose concentrations of 1%, 5% and 10% (w/v) in methyl ethyl ketone (MEK) DPX-C (Di-Cloro-Di-p-Xililene) were evaluated in the main study.
- No. of animals per dose:
- 8 (2 mice/group) for preliminary assay, and 25 (5 mice/group) for main study.
- Details on study design:
- Females (nulliparous and non-pregnant).
- Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 1.63
- Test group / Remarks:
- 1% MEK
- Parameter:
- SI
- Value:
- 2.51
- Test group / Remarks:
- 5% MEK
- Parameter:
- SI
- Value:
- 5.31
- Test group / Remarks:
- 10% MEK
- Parameter:
- EC3
- Value:
- 5.88
- Test group / Remarks:
- 10% MEK
Applicant's summary and conclusion
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- The SI obtained for DPX-C (Di-Cloro-Di-p-Xililene) at 10% concentration showed a greater than three fold increase over the control value with an EC3 value found to be 5.88%. Therefore, DPX-C (Di-Cloro-Di-p-Xililene) demonstrates moderate sensitiser potential in the local lymph node assay.
- Executive summary:
This study was conducted to evaluate the skin sensitisation potential of DPX-C (Di-Cloro-Di-p-Xililene) in CBA/J strain mice in compliance with the OECD test guidelines for the local lymph node assay (LLNA).
A preliminary assay was conducted using treatment conditions similar to the main assay, in order to identify the appropriate test concentrations for the sensitisation assay.
Five groups of mice (each comprising 5 females) were selected for the main experiment. Based on the results from the preliminary assay, three groups were treated with DPX-C (Di-Cloro-Di-p-Xililene) at concentrations of 1%, 5% and 10% (w/v) in methyl ethyl ketone (MEK) for three consecutive days (days 0, 1 and 2) on the dorsum of both ears (25mL per ear). In addition, one group served as the vehicle control and was treated with methyl ethyl ketone (MEK) and another group served as the positive control and was treated with HCA (a-hexylcinnamaldehyde)at a concentration of 25% (v/v) in methyl ethyl ketone (MEK).
Group mean body weights of treated animals were comparable with the control group and there were no indications of skin irritation at the treatment site or systemic toxicity in DPX-C (Di-Cloro-Di-p-Xililene) treated animals.
On day 5, the uptake of intravenously injected3H-methyl thymidine into the auricular (local) lymph nodes draining at the site of chemical application was measured (5 hours post-administration) to assess the lymph node proliferative response. Stimulation indices (SI) for the 1%, 5% and 10% (w/v) in methyl ethyl ketone (MEK) of DPX-C (Di-Cloro-Di-p-Xililene) treated groups were 1.63, 2.51 and 5.31, respectively.
The SI obtained forDPX-C (Di-Cloro-Di-p-Xililene)at 10% concentration showed a greater than three fold increase over the control value with an EC3value found to be 5.88%. Therefore,DPX-C (Di-Cloro-Di-p-Xililene)demonstrates moderate sensitiser potential in the local lymph node assay.
Apositive response for HCA (SI = 11.40), in agreement with historical controls, confirmed the reliability of the test procedure.
Based on the results of this study, an indication of the classification forDPX-C (Di-Cloro-Di-p-Xililene) isas follows:
Globally Harmonized System of Classification and Labeling of Chemicals (GHS2015): Sub Category 1B.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
